Market closed · Next open: Wednesday 9:30 AM ET
Last update: Jul 21, 2026, 6:24 PM ET
Hinge Health, Inc.
$84.35 3.82% today
Market Closed

Why Hinge Health, Inc. (HNGE) stock moved

Updated Jul 22, 2026

Hinge Health, Inc. (HNGE) shares fell 3.8% to $84.35 as of July 22, 2026, a moderate decline from the prior close of $87.70. BestStocks flagged the session as a major change for HNGE. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for HNGE, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

HNGE fell 3.8% to $84.35

HNGE fell 3.8% in its latest session, moving from $87.70 to $84.35.

RiskWeak confidence
Rel. volume
1.2×
Normal
Vs peers
No comparable peers
Market cap
$6.5B
New York Stock Exchange
Analyst target
$86
+2.1% vs price
Price chart
Jun 22 – Jul 22
VVVVVVV$69$79$90Jun 22Jun 29Jul 8Jul 15Jul 22
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Hinge Health, Inc. investors

For Hinge Health, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Hinge Health, Inc. (HNGE) moved +1.35% from $88.80 to $90.00 on 2026-07-13, reaching a new 30-day high; Hinge Health, Inc. (HNGE) moved +1.60% from $88.50 to $89.92 on 2026-07-09. Weighing against that: Negative session, down 3.8%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $86.15, implying +2.1% upside from $84.35. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 13 days out, the next report is the most likely near-term test of the move.

HNGE price reaction

HNGE last traded at $84.35, down $3.35 (-3.82%) from the previous close of $87.70. The session traded on 1.2× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $68.85 and $90.00, and it currently sits about 73% of the way up that band.

Bullish and bearish analyst opinions on Hinge Health, Inc. (HNGE)

The consensus analyst price target on Hinge Health, Inc. (HNGE) is $86.15, 2.1% above the recent $84.35. Over the past 90 days analysts logged 0 upgrades, 21 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HNGE line up.

The bullish case

  • Wall Street's consensus price target of $86.15 implies +2.1% upside from $84.35.
  • The Street's most bullish target is $125.00 (+48.2%).
  • Hinge Health, Inc. (HNGE) moved +1.35% from $88.80 to $90.00 on 2026-07-13, reaching a new 30-day high.
  • Positive price momentum.

The bearish case

  • The most bearish analyst target is $45.00 (-46.7%).
  • Negative session, down 3.8%.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Jul 22, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $86+2.1%
= 21 maintains
Canaccord Genuity maintained Buy · 2026-07-21
SEC filings watch
8-K2026-06-09
Material event — review for impact
high
8-K2026-06-04
Material event — review for impact
high
10-Q2026-05-07
Quarterly financial results
medium
8-K2026-05-05
Material event — review for impact
high
Peer context
HNGE-3.8%

Previous notable changes for HNGE

Risk2026-07-15-4.0%
Hinge Health, Inc. (HNGE) moved -3.99% from $89.31 to $85.75 on 2026-07-15. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average at 1.1x.
Activity2026-07-13+1.4%
Hinge Health, Inc. (HNGE) moved +1.35% from $88.80 to $90.00 on 2026-07-13, reaching a new 30-day high. Volume was 1.6x the 5-day average. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
Activity2026-07-09+1.6%
Hinge Health, Inc. (HNGE) moved +1.60% from $88.50 to $89.92 on 2026-07-09. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move appears to be driven by technical momentum, as the stock reached a new 30-day high on below-average volume (0.7x the 5-day average).
Activity2026-07-07+0.9%via Business Wire
Hinge Health announced via Business Wire (July 6) that it will report Q2 2026 earnings after market close on August 4, 2026. HNGE rose 5.10% to $88.34 from $84.05. Volume of 326,058 shares at 62 minutes into the session tracked at 0.82x the historical average—normal for this time of day.
Upcoming catalysts & outlook
Next earnings
2026-08-04 (est.)
in 13 days
10-Q Filing (est.)
2026-08-06
Medium impact
Thesis shift
Neutral / Mixed
bullish signal
Risk level
High
from change events

Frequently asked questions about HNGE

Why did Hinge Health, Inc. (HNGE) stock move?

HNGE fell 3.8% to $84.35. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did HNGE stock fall?

HNGE lost 3.82% ($3.35) versus the prior close of $87.70, last trading at $84.35 on 1.2× average volume.

When is Hinge Health, Inc.'s next earnings date?

HNGE's next earnings report is estimated for 2026-08-04 — about 13 days away.

What is the analyst price target for HNGE?

The consensus analyst price target for HNGE is $86.15, about 2.1% above the current $84.35. Over the past 90 days, analysts recorded 0 upgrades, 21 maintains, and 0 downgrades.

How BestStocks tracks HNGE

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HNGE-specific materiality thresholds, triggering an evidence check. It draws on 9 tracked change events for HNGE, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 22, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.